BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q2 2023 Earnings Call Transcript August 14, 2023
BioXcel Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.83 EPS, expectations were $1.72.
Operator: Good morning, and welcome to BioXcel Therapeutics’ Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] After the speakers’ presentation, there will be a question-and-answer session. [Operator...
